Allow me to make my own assumptions in comparison to yours:
$5.5M drug manufacturing cost (placement sum) This includes manufacturing set up, batch creation, process development focussing on scalability and productivity improvement, including charscterisation studies and validation running simultaneously with the trial patient dosing, enhancing ease of submission to regulatory approvals for future commercialisation.
$1.9M needed to continue dosing for remainimg 6 months of dosing to the 74 patients.
$1,900,000 ÷ 74 ÷ 26wks = $974 per jab each week.
ANP Price at posting:
9.9¢ Sentiment: Buy Disclosure: Held
